Page last updated: 2024-12-07

eudragit rs

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Eudragit RS is a copolymer of methacrylic acid and ethyl acrylate. It is a synthetic polymer that is commonly used as a pharmaceutical coating material. Eudragit RS is known for its ability to form a film that is resistant to gastric fluids but dissolves in the intestinal fluid. This property makes it useful for formulating sustained-release and enteric-coated tablets and capsules. It is often used to protect drugs from degradation in the stomach and to control the release of drugs in the intestines. Eudragit RS is studied for its potential to improve drug delivery efficiency, reduce side effects, and enhance patient compliance.'

Eudragit RS: copolymer of acrylic & methacrylic acid esters & quaternary ammonium groups; used for microcapsules [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID104931
MeSH IDM0144225

Synonyms (4)

Synonym
33434-24-1
eudragit rs
ethyl prop-2-enoate;methyl 2-methylprop-2-enoate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride
ammonio methacrylate copolymer type a (100 mg)

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" In vivo pharmacokinetic and pharmacodynamic studies in male Wistar rats demonstrated that enteric coated microparticles sustained release of LPZ and promoted ulcer healing activity."( A novel once daily microparticulate dosage form comprising lansoprazole to prevent nocturnal acid breakthrough in the case of gastro-esophageal reflux disease: preparation, pharmacokinetic and pharmacodynamic evaluation.
Alai, M; Lin, WJ, 2013
)
0.39

Compound-Compound Interactions

ExcerptReferenceRelevance
" However, Eudragit RS and Eudragit RL in combination with inulin made free films which had more swelling and permeation of drug in the colonic medium rather than the other media."( Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
Afrasiabi Garekani, H; Akhgari, A; Farahmand, F; Sadeghi, F; Vandamme, TF, 2006
)
0.74

Bioavailability

ExcerptReferenceRelevance
"The bioavailability of percutaneous nifedipine was studied in rats."( Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats.
Kondo, S; Sugimoto, I; Yamanaka, C, 1987
)
0.27
"01 IU/mL and an average aPTT of 24 seconds (2-fold increase) were obtained 7 hours after oral dosing of Eudragit RL/PCL NPs containing heparin, exhibiting an absolute bioavailability of 23%."( In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits.
Hoffman, M; Jiao, Y; Lecompte, T; Maincent, P; Marchand-Arvier, M; Ubrich, N; Vigneron, C, 2002
)
0.31
"The pharmacological profile of the topical IBU-RS nanosuspension formulation described in this study indicates that the dispersion of the drug within RS polymer nanoparticles increased its ocular bioavailability and ultimately its pharmacological activity."( Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension.
Bucolo, C; Maltese, A; Pignatello, R; Puglisi, G,
)
0.37
"Weakly basic drugs, such as verapamil hydrochloride, that are poorly soluble in neutral/alkaline medium may have poor oral bioavailability due to reduced solubility in the small intestine and colon."( Film coated pellets containing verapamil hydrochloride: enhanced dissolution into neutral medium.
Munday, DL, 2003
)
0.32
" To investigate the ocular bioavailability of cloricromene after inclusion in the polymer matrix, the new nanoparticle system was topically administered in the rabbit eye and compared with an aqueous solution of the same drug."( Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene.
Bucolo, C; Busà, B; Maltese, A; Maugeri, F; Pignatello, R; Puglisi, G, 2004
)
0.32
" These systems should also provide postruminal bioavailability and controlled release of the active ingredient."( Bilayer tablets based on poly (epsilon-caprolactone) and polymethylmethacrilates as controlled-release systems for ruminants.
Gavini, E; Giunchedi, P; Sanna, V, 2004
)
0.32
" Based on comparison of the area under the blood concentration-time curve values, the relative bioavailability of CyA from each nanoparticulate formulation ranged from 20 to 35%."( Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles.
Bodmeier, R; Hoffman, M; Maincent, P; Schmidt, C; Ubrich, N, 2005
)
0.58
" Based on the technological results, AD6-loaded Eudragit Retard nanoparticle suspensions appear to offer promise as a means to improving the shelf life and bioavailability of this drug after ophthalmic application."( Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.
Bucolo, C; Maltese, A; Maugeri, F; Pignatello, R; Puglisi, G; Ricupero, N, 2006
)
0.33
"A multiple-unit floating drug delivery system based on gas formation technique was developed in order to prolong the gastric residence time and to increase the overall bioavailability of the dosage form."( Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
Limmatvapirat, S; Paeratakul, O; Puttipipatkhachorn, S; Sungthongjeen, S, 2006
)
0.33
"The study was designed to evaluate the effect of delayed release (DR) on absorption and bioavailability of intestinally metabolized drugs after oral dosing, using the HMG-CoA reductase inhibitor simvastatin, a CYP3A substrate, as a model drug."( Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms.
Amidon, GL; Hilfinger, JM; Kijek, P; Kim, JS; Langguth, P; Staubach, P; Tubic-Grozdanis, M, 2008
)
0.35
"Simvastatin bioavailability was increased by a factor of three, as compared to the reference formulation Zocor."( Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms.
Amidon, GL; Hilfinger, JM; Kijek, P; Kim, JS; Langguth, P; Staubach, P; Tubic-Grozdanis, M, 2008
)
0.35
"The interplay between gastrointestinal physiology (lower CYP 3A expression in the distal ileum and the colon) and formulation design (zero-order controlled release after a predetermined lag-time) resulted in successful absorption and bioavailability improvement and represent a viable strategy to reduce the dose of CYP 3A drugs."( Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms.
Amidon, GL; Hilfinger, JM; Kijek, P; Kim, JS; Langguth, P; Staubach, P; Tubic-Grozdanis, M, 2008
)
0.35
"A gastro retentive floating drug delivery system with multiple-unit minitab's based on gas formation technique was developed in order to prolong the gastric residence time and to increase the overall bioavailability of the drug."( Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation.
Chinnala, KM; Kesavan, B; Meka, L; Vobalaboina, V; Yamsani, MR, 2008
)
0.35
" The relative bioavailability of the sustained-release pellets was studied in six beagle dogs after oral administration in a fast state using a commercially available immediate release tablet as a reference."( Preparation and bioavailability of sustained-release doxofylline pellets in beagle dogs.
He, HB; Huang, HF; Lu, Y; Tang, X, 2008
)
0.35
" Its oral bioavailability is 25-35% because of first pass metabolism."( Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.
Babu, P; Pandey, G; Thimmasetty, J, 2008
)
0.35
" In vivo study, conducted in Wistar rats, proved that elevated serum sCT levels could be sustained for 3 days after subcutaneous administration of PLGA nanoparticles and the achieved bioavailability was increased compared to sCT solution."( Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
Glowka, E; Leroy, P; Lulek, J; Maincent, P; Sapin-Minet, A, 2010
)
0.36
" The wafers were tested for their physical characteristics, ex vivo mucoadhesion strength, ex vivo mucoadhesion time, in vitro drug release, and in vitro permeation and in vivo bioavailability studies."( Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension.
Ali, J; Ali, M; Hassan, N, 2010
)
0.36
"The bioavailability of low molecular weight heparin (LMWH) has been increased by encapsulation in nanoparticles."( Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages.
Attik, G; Bottin, MC; Duval, RE; Eidi, H; Hamouia, A; Joubert, O; Maincent, P; Rihn, BH, 2010
)
0.36
" The dissolution rate and bioavailability of dexibuprofen loaded in dry elixir were increased compared with those of dexibuprofen powder."( Dry elixir formulations of dexibuprofen for controlled release and enhanced oral bioavailability.
Kim, CK; Kim, JK; Kim, SR; Park, JS, 2011
)
0.37
" The floating pellets were evaluated for SEM, floating characteristic parameters, in vitro release and bioavailability in New Zealand rabbits."( A floating multiparticulate system for ofloxacin based on a multilayer structure: In vitro and in vivo evaluation.
He, H; Lin, X; Liu, Z; Tang, J; Tang, X; Tao, X; Xu, M; Zhang, C; Zhang, Y, 2012
)
0.38
" Finally, we confirmed that oral OMT with sustained release led to a gradual sustained plasma profile of both OMT, with a reduction in its bioavailability, and MT with an increase in the bioavailability compared with that of oral OMT with immediate release."( Development of an osmotically-driven pellet coated with acrylic copolymers (Eudragit® RS 30 D) for the sustained release of oxymatrine, a freely water soluble drug used to treat stress ulcers (I): in vitro and in vivo evaluation in rabbits.
Cui, F; Li, X; Liu, S; Piao, H, 2013
)
0.39
" The type of solvent did not distinctly influence the particle properties or insulin stability but modified significantly the performance in vivo in rats, NPs prepared with glycofurol led to a bioavailability of F=1."( Oral insulin delivery in rats by nanoparticles prepared with non-toxic solvents.
Béduneau, A; Javot, L; Lamprecht, A; Pellequer, Y; Viehof, A, 2013
)
0.39
" Moreover, in vivo bioavailability of LP-MS was evaluated with conventional enteric microspheres (enteric MS) as reference."( Novel pH-sensitive lipid-polymer composite microspheres of 10-hydroxycamptothecin exhibiting colon-specific biodistribution and reduced systemic absorption.
Gan, L; Gan, Y; Gao, YP; Zhang, XX; Zhu, CL, 2013
)
0.39
"Oral bioavailability of low molecular weight heparin (LMWH) can be achieved by several advanced drug delivery approaches."( Oral delivery of low molecular weight heparin by polyaminomethacrylate coacervates.
Lamprecht, A; Viehof, A, 2013
)
0.39
" Objective of the present study is to increase the topical ocular bioavailability and to sustain the release of drug for longer time."( Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
Gupta, RN; Jha, AK; Pandey, R; Verma, P,
)
0.13
"Effective clinical utilization of non-steroidal anti-inflammatory drugs such as diclofenac sodium (DS) is significantly limited by their ulcerogenic potential and poor bioavailability after oral administration, thus necessitating the need for a better carrier to minimize these obvious limitations."( Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
Adedokun, MO; Attama, AA; Kenechukwu, FC; Momoh, MA; Odo, CE, 2014
)
0.4
" Bioavailability experiment was carried out by administering the pulsatile release pellets to rats compared with marketed rapid release tablets Yisu."( A novel pulsatile drug delivery system based on the physiochemical reaction between acrylic copolymer and organic acid: in vitro and in vivo evaluation.
Li, X; Qi, X; Wu, Z; Xing, J; Zhang, Z; Zhu, X, 2014
)
0.4
"The current studies entail successful formulation of systematically optimized (OPT) nanoparticulate drug delivery system to increase the oral bioavailability using Eudragit RL 100 of trans-resveratrol (t-RVT), and evaluate their in-vitro/in-vivo performance."( In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Pai, RS; Singh, G, 2014
)
0.4
"25-fold) indicated significant enhancement in the rate and extent of bioavailability by the optimized trans-resveratrol-loaded Eudragit RL 100 nanoparticles (OPT-t-RVT NPs) compared with pure drug."( In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Pai, RS; Singh, G, 2014
)
0.4
"The results, therefore, insight into the role of solubility enhancement and trounce enterohepatic recirculation for improving the oral bioavailability of t-RVT."( In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Pai, RS; Singh, G, 2014
)
0.4
" The relative bioavailability of the optimized microspheres was compared with CTZ marketed product after oral administration on healthy human volunteers using a double blind, randomized, cross-over design."( Statistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugs.
Ahmed, OA; Ahmed, TA; Alsawahli, M; El-Helw, AR; El-Say, KM; Fahmy, UA; Hosny, KM; Kharshoum, RM, 2015
)
0.42
"91-fold) indicated significant enhancement in the rate and extent of bioavailability by the OPT formulation compared to pure drug."( Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Pai, RS; Singh, G, 2016
)
0.43
"Effective clinical utilisation of non-steroidal anti-inflammatory drugs, such as diclofenac sodium (DS) is significantly limited by their ulcerogenic potential and poor bioavailability after oral administration."( Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery.
Bozkır, A; Canefe, K; Devrim, B; Oz, UC, 2015
)
0.42
"Ocular topically applied Vancomycin (VCM) suffers poor bioavailability due to its high molecular weight and hydrophilicity."( Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
El-Laithy, HM; Elkheshen, SA; Essam, T; Fahmy, RH; Yousry, C, 2017
)
0.46
" However, it has low oral bioavailability (25-35%) due to its high first-pass hepatic metabolism."( Carvedilol-loaded nanocapsules: Mucoadhesive properties and permeability across the sublingual mucosa.
Beck, RC; Chaves, PD; Frank, LA; Guterres, SS; Ourique, AF; Pohlmann, AR, 2017
)
0.46
" They have also been tested in vivo for their oral bioavailability and potential side effects."( Design, characterization and in vivo evaluation of modified release baclofen floating coated beads.
Abdelkader, H; Ibrahim, M; Naguib, YW; Sarhan, HA, 2020
)
0.56

Dosage Studied

A microparticulate dosage form for a highly soluble drug, diltiazem hydrochloride, was formulated with Eudragit RS100 and RL100. A colorimetric ion-pair complexation method has been developed which provides a simple and rapid way of quantifying the dosage forms.

ExcerptRelevanceReference
" The effects of different polymer ratios of Eudragit RS30D and Eudragit RL30D, different particle sizes, and different combination of various formulations of solid dispersions on the in vitro release kinetics of drugs from the dosage forms were investigated."( Development of extended-release solid dispersions of nonsteroidal antiinflammatory drugs with aqueous polymeric dispersions: optimization of drug release via a curve-fitting technique.
Ho, C; Hwang, GC, 1992
)
0.54
"A colorimetric ion-pair complexation method has been developed which provides a simple and rapid way of quantifying Eudragit RS100 and RL100 in pharmaceutical dosage forms."( A simple and rapid method for the quantification of Eudragit RS100 and RL100 poly(methacrylates) in sustained-release dosage forms.
Hansraj, BR; Khan, KA; Melia, CD; Wilding, IR, 1991
)
0.74
" In contrast, no appreciable increases in the percutaneous absorption of nifedipine from PG or IPM above controls were observed for pretreatment of the dosing site with acetone."( Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats.
Kondo, S; Sugimoto, I; Yamanaka, C, 1987
)
0.27
" The low permeability of a water-soluble drug, chlorpheniramine maleate, and the weak mechanical properties of Aquacoat films could suggest osmotic driven/rupturing effects as the release mechanisms from Aquacoat-coated dosage forms."( Mechanical properties of dry and wet cellulosic and acrylic films prepared from aqueous colloidal polymer dispersions used in the coating of solid dosage forms.
Bodmeier, R; Paeratakul, O, 1994
)
0.29
"Eudragit RL and RS 30D are pseudolatexes frequently used in the coating of solid dosage forms."( The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D.
Bodmeier, R; Guo, X; Sarabia, RE; Skultety, PF, 1996
)
0.5
"The purpose of this study was to prepare and evaluate an enteric coated dosage form of nicardipine hydrochloride (NCH)-loaded microspheres for delivery over a 12-hr period."( Influence of swelling degree on release of nicardipine hydrochloride from acrylic microspheres prepared by solvent evaporation method.
Baykara, T; Dinç, E; Onur, F; Yüksel, N, 1998
)
0.3
"A microparticulate dosage form for a highly soluble drug, diltiazem hydrochloride, was formulated with Eudragit RS100 and RL100 using a novel dual polymer technique."( Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
Das, NG; Das, SK,
)
0.59
"01 IU/mL and an average aPTT of 24 seconds (2-fold increase) were obtained 7 hours after oral dosing of Eudragit RL/PCL NPs containing heparin, exhibiting an absolute bioavailability of 23%."( In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits.
Hoffman, M; Jiao, Y; Lecompte, T; Maincent, P; Marchand-Arvier, M; Ubrich, N; Vigneron, C, 2002
)
0.31
" This work illustrates the potential for an artificial neural network, GRNN, to assist in development of extended-release dosage forms."( The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance.
Djurić, Z; Ibrić, S; Jovanović, M; Parojcić, J; Solomun, L, 2002
)
0.52
" Its dosage rate in the treatment of myastenia gravis is frequent due to the short half-life and it exhibits side effects."( Preparation and in vitro evaluation of pyridostigmine bromide microparticles.
Demirel, M; Hegazy, N; Yazan, Y, 2002
)
0.31
"Inert matrices of didanosine (ddI) were elaborated as controlled release dosage forms, using two different types of polymers: Eudragit RS-PM, an anionic acrylic acid copolymer, and Ethocel 100 Premium, an ethylcellulose."( Eudragit RS-PM and Ethocel 100 Premium: influence over the behavior of didanosine inert matrix system.
Alvarez-Fuentes, J; Fernández-Arévalo, M; Rabasco, AM; Sánchez-Lafuente, C, 2002
)
1.96
"Eudragit RL (ERL) and RS (ERS) are polymethacrylate co-polymers, used in film coating of sustained release dosage forms, possessing some hydrophilic properties due to the presence of quaternary ammonium groups (QAG), where ERL contains more of such groups, hence more permeable, than ERS."( Lactic acid-induced modifications in films of Eudragit RL and RS aqueous dispersions.
Abd-Elbary, A; El-Samaligy, M; Omari, DM; Sallam, A, 2004
)
0.32
"4, to study the release behavior of the dosage forms in the intestinal environment."( Bilayer tablets based on poly (epsilon-caprolactone) and polymethylmethacrilates as controlled-release systems for ruminants.
Gavini, E; Giunchedi, P; Sanna, V, 2004
)
0.32
"Percolation theory has been used with great interest in understanding the design and characterization of dosage forms."( Comparison studies on the percolation thresholds of binary mixture tablets containing excipients of plastic/brittle and plastic/plastic deformation properties.
Amin, MC; Fell, JT, 2004
)
0.32
"A multiple-unit floating drug delivery system based on gas formation technique was developed in order to prolong the gastric residence time and to increase the overall bioavailability of the dosage form."( Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
Limmatvapirat, S; Paeratakul, O; Puttipipatkhachorn, S; Sungthongjeen, S, 2006
)
0.33
" Through the printing of release-retardation materials, 3DP processes could easily prepare tablets with high dosage and special design features for furnishing the desired drug release characteristics."( Tablets with material gradients fabricated by three-dimensional printing.
Huang, WD; Liu, J; Wang, YG; Xu, H; Yang, XL; Yu, DG, 2007
)
0.34
" The release rate of theophylline decreased significantly over time from pellets coated with an acrylic dispersion containing 10% albumin when there was no acidification of the acrylic dispersion; however, when pellets were coated with an acidified EUDRAGIT/albumin dispersion, the theophylline release rate was stable for dosage forms stored in the absence of humidity."( Use of proteins to minimize the physical aging of EUDRAGIT sustained release films.
Infeld, MH; Kucera, SA; Malick, AW; McGinity, JW; Shah, NH; Zheng, W, 2007
)
0.34
" The potential histological changes were also evaluated after direct dosing of suspensions of naproxen alone and powdered mixtures of inclusion complex-loaded tablet into rat intestinal segments."( Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
Lee, BJ; Lee, MK; Piao, ZZ, 2008
)
0.35
"To target drug release and to assess regional gastrointestinal absorption of the CYP 3A substrate simvastatin from the distal parts of the intestine, delayed release film coated tableted oral dosage forms were developed."( Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms.
Amidon, GL; Hilfinger, JM; Kijek, P; Kim, JS; Langguth, P; Staubach, P; Tubic-Grozdanis, M, 2008
)
0.35
" The overall metabolite levels from the immediate release capsules tended to be higher throughout the period studied than the metabolite levels following administration of Zocor and simvastatin delayed release dosage form."( Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms.
Amidon, GL; Hilfinger, JM; Kijek, P; Kim, JS; Langguth, P; Staubach, P; Tubic-Grozdanis, M, 2008
)
0.35
" Stability study of pellets was performed as capsule dosage form in aluminium-PVDC packaging mode at room temperature, 40 degrees C, 40 degrees C/75%RH & 30 degrees C/70%RH for three months."( Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Islam, KM; Jalil, RU; Kibria, G, 2009
)
0.35
" Since parenteral administration requires medical assistance and is not the most convenient route of application, the development of an oral dosage form of heparin would improve patients' comfort and replace vitamin K antagonists."( Granules in the improvement of oral heparin bioavailability.
Bonneaux, F; Lecompte, T; Maincent, P; Rabiskova, M; Scala-Bertola, J, 2009
)
0.35
" The obtained new insight into the occurring drug-polymer interactions can help to facilitate the development/optimisation of this type of dosage forms."( Characterisation of quaternary polymethacrylate films containing tartaric acid, metoprolol free base or metoprolol tartrate.
Glaessl, B; Rades, T; Siepmann, F; Siepmann, J; Tucker, I, 2009
)
0.35
"This study presents LMWH in a pellet dosage form, which compared to nano- or microparticles, may offer a more convenient and industrializable way of manufacture leading to an easier scale-up process."( Pellets for oral administration of low-molecular-weight heparin.
Bonneaux, F; Gajdziok, J; Lecompte, T; Maincent, P; Rabisková, M; Sapin, A; Scala-Bertola, J, 2009
)
0.35
" Our results suggest that CDDE may be potential oral dosage forms to control the release and to improve the bioavailability of poorly water-soluble dexibuprofen."( Dry elixir formulations of dexibuprofen for controlled release and enhanced oral bioavailability.
Kim, CK; Kim, JK; Kim, SR; Park, JS, 2011
)
0.37
" Therefore, the aim of the present study was to produce an effective drug-loaded dosage form that is able to control the release of hydroxyzine hydrochloride into the skin."( In vitro and in vivo evaluation of hydroxyzine hydrochloride microsponges for topical delivery.
latif Aziz, R; Soliman, II; Zaki Rizkalla, CM, 2011
)
0.37
" Thus, developed formulation of olanzapine is expected to improve the patient compliance, form better dosage regimen, and provide maintenance therapy to psychotic patients."( Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine.
Aggarwal, G; Dhawan, S; Harikumar, SL,
)
0.13
" Coated buccal matrix tablets may represent a potential alternative dosage form for systemic delivery of MMI in hyperthyroidism management."( Buccal delivery of methimazole as an alternative means for improvement of drug bioavailability: permeation studies and matrix system design.
De Caro, V; Giandalia, G; Giannola, LI; Siragusa, MG, 2012
)
0.38
" In other words, the microparticulate dosage form provided effective drug concentration for a longer period as compared to conventional extended release dosage form, and showed sufficient anti-acid secretion activity to treat acid related disorders including the enrichment of nocturnal acid breakthrough event based on a once daily administration."( A novel once daily microparticulate dosage form comprising lansoprazole to prevent nocturnal acid breakthrough in the case of gastro-esophageal reflux disease: preparation, pharmacokinetic and pharmacodynamic evaluation.
Alai, M; Lin, WJ, 2013
)
0.39
" Pellets are a dosage form that is frequently used in such formulations."( A study on the applicability of in-line measurements in the monitoring of the pellet coating process.
Hudovornik, G; Korasa, K; Vrečer, F, 2015
)
0.42
" The obtained new knowledge can be helpful for the development of novel coating materials (based on QPM-MAS blends) for controlled-release dosage forms."( Quaternary polymethacrylate-magnesium aluminum silicate films: Water uptake kinetics and film permeability.
Pongjanyakul, T; Rongthong, T; Siepmann, F; Siepmann, J; Sungthongjeen, S, 2015
)
0.42
"Alcohol-induced dose dumping is a serious concern for the orally administered prolonged release dosage forms."( Development and Optimization of a Novel Prolonged Release Formulation to Resist Alcohol-Induced Dose Dumping.
Deulkar, VS; Gannu, R; Gujjar, CY; Rallabandi, BC, 2016
)
0.43
" Thus, the film may serve as an alternative therapy to oral dosage form of SS."( Formulation optimization and characterization of transdermal film of simvastatin by response surface methodology.
Parhi, R; Suresh, P, 2016
)
0.43
"An in situ forming gel is a dosage form which is promised for site-specific therapy such as periodontal pocket of periodontitis treatment."( Designing Solvent Exchange-Induced In Situ Forming Gel from Aqueous Insoluble Polymers as Matrix Base for Periodontitis Treatment.
Phaechamud, T; Srichan, T, 2017
)
0.46
" This study highlighted the suitability of using CAR-loaded nanocapsules in the development of innovative sublingual dosage forms."( Carvedilol-loaded nanocapsules: Mucoadhesive properties and permeability across the sublingual mucosa.
Beck, RC; Chaves, PD; Frank, LA; Guterres, SS; Ourique, AF; Pohlmann, AR, 2017
)
0.46
"The 3D printing technique of fused deposition modeling® (FDM) has lately come into focus as a potential fabrication technique for pharmaceutical dosage forms and medical devices that allows the preparation of delivery systems with nearly any shape."( Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants.
Bogdahn, M; Franz, C; Kempin, W; Koster, LC; Schneider, F; Seidlitz, A; Weitschies, W, 2017
)
0.46
" Transdermal drug delivery system is the main route with discrete, self-contained dosage forms when placed on the skin, transporting the medicament through the skin into the systemic circulation in a wellcontrolled manner."( Design and Evaluation of Transdermal Patches of Timolol Maleate.
Jamakandi, VG; Panchayya Hiremath, SS; Reddy, JJ, 2018
)
0.48
"Controlled release dosage forms provide sustained therapeutics effects for prolonged period of time and improve patient compliance."( Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
Jan, SU; Khan, GM; Khan, KA; Mehsud, S; Rehman, A, 2018
)
0.48
"Orodispersible films (ODFs) are an advantageous dosage form to accomplish patient convenience and compliance in oral drug delivery."( Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Breitkreutz, J; Preis, M; Speer, I, 2018
)
0.48
"The objective of this study was to formulate once-a-day extended-release (ER) pellet system of imidafenacin (IDN), a recently approved urinary antispasmodic agent with twice-a-day dosing regimen."( Novel Extended-Release Multiple-Unit System of Imidafenacin Prepared by Fluid-Bed Coating Technique.
Choi, YW; Goh, MS; Ho, MJ; Im, SH; Kang, MJ; Kim, CH; Lee, ES; Shin, TH, 2018
)
0.48
"The present investigation explores the development and characterization of moxifloxacin hydrochloride and ketorolac tromethamine combination loaded Eudragit RL 100 nanosuspension for ocular drug delivery in order to overcome the problems associated with conventional dosage forms."( Eudragit RL100 Based Moxifloxacin Hydrochloride and Ketorolac Tromethamine Combination Nanoparticulate System for Ocular Drug Delivery.
Pawar, P; Salvi, V, 2020
)
0.56
" It was deducted from the current study that the Eudragit RL 100 can be efficiently incorporated in the formulation of controlled release dosage forms with predictable kinetics."( Formulation and assessment of controlled release tablets of famotidine by using eudragit RL 100 polymer.
Ahmad Khan, K; Gul, R; Rabani, T; Rashid, F; Razaque, G; Tufail, M; Umer Jan, S, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (335)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (0.90)18.7374
1990's21 (6.27)18.2507
2000's147 (43.88)29.6817
2010's145 (43.28)24.3611
2020's19 (5.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.42 (24.57)
Research Supply Index5.95 (2.92)
Research Growth Index5.65 (4.65)
Search Engine Demand Index57.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (1.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other371 (98.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]